Literature DB >> 20303141

Mitogenic cardiomyopathy: a lethal neonatal familial dilated cardiomyopathy characterized by myocyte hyperplasia and proliferation.

Kenneth T E Chang1, Glenn P Taylor, Wendy S Meschino, Paul F Kantor, Ernest Cutz.   

Abstract

Pediatric cardiomyopathies are a heterogenous group of conditions of which dilated cardiomyopathies are the most common clinicomorphologic subtype. However, the etiology and pathogenesis of many cases of dilated cardiomyopathies remain unknown. We describe a series of 5 cases of a rare but clinically and histologically distinctive dilated cardiomyopathy that was uniformly lethal in early infancy. The 5 cases include 2 pairs of siblings. There was parental consanguinity in 1 of the 2 pairs of siblings. Death occurred in early infancy (range, 22-67 days; mean, 42 days) after a short history of general lethargy, decreased feeding, respiratory distress, or cyanosis. There was no specific birth or early neonatal problems. Autopsy revealed congestive cardiac failure and enlarged, dilated hearts with ventricular dilatation more pronounced than atrial dilatation, and endocardial fibroelastosis. Histology showed prominent hypertrophic nuclear changes of cardiac myofibers and markedly increased myocyte mitotic activity including occasional atypical mitoses. Immunohistochemical staining for Mib1 showed a markedly increased proliferative index of 10% to 20%. Ancillary investigations, including molecular studies, did not reveal a primary cause for the cardiomyopathies. This distinctive dilated cardiomyopathy characterized by unusual histologic features of myocyte nuclear hypertrophy and marked mitotic activity is lethal in early infancy. Its occurrence in 2 pairs of siblings suggests familial inheritance. Although the underlying molecular pathogenesis remains to be elucidated, it is important to recognize this distinctive entity for purposes of genetic counseling. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20303141     DOI: 10.1016/j.humpath.2009.12.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.

Authors:  Kristin M Burns; Barry J Byrne; Bruce D Gelb; Bernhard Kühn; Leslie A Leinwand; Seema Mital; Gail D Pearson; Mark Rodefeld; Joseph W Rossano; Brian L Stauffer; Michael D Taylor; Jeffrey A Towbin; Andrew N Redington
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

2.  Innervating sympathetic neurons regulate heart size and the timing of cardiomyocyte cell cycle withdrawal.

Authors:  R E Kreipke; S J Birren
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

3.  PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.

Authors:  Peter Tzu-Yu Chien; Hsi-Lung Hsieh; Pei-Ling Chi; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Exome sequencing establishes diagnosis of Alström syndrome in an infant presenting with non-syndromic dilated cardiomyopathy.

Authors:  Pamela A Long; Jared M Evans; Timothy M Olson
Journal:  Am J Med Genet A       Date:  2015-02-23       Impact factor: 2.802

5.  Prolonged cardiac NR4A2 activation causes dilated cardiomyopathy in mice.

Authors:  Sadia Ashraf; Heinrich Taegtmeyer; Romain Harmancey
Journal:  Basic Res Cardiol       Date:  2022-07-01       Impact factor: 12.416

6.  Cardiomyocyte proliferation contributes to heart growth in young humans.

Authors:  Mariya Mollova; Kevin Bersell; Stuart Walsh; Jainy Savla; Lala Tanmoy Das; Shin-Young Park; Leslie E Silberstein; Cristobal G Dos Remedios; Dionne Graham; Steven Colan; Bernhard Kühn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-09       Impact factor: 11.205

7.  Effects of IGF-1 on I(K) and I(K1) Channels via PI3K/Akt Signaling in Neonatal Cardiac Myocytes.

Authors:  Richard M Millis; Zikiar V Alvin; Aiqiu Zhao; Georges E Haddad
Journal:  Int J Cell Biol       Date:  2012-06-18

8.  Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations.

Authors:  Marie Demion; Jérôme Thireau; Mélanie Gueffier; Amanda Finan; Ziad Khoueiry; Cécile Cassan; Nicolas Serafini; Franck Aimond; Mathieu Granier; Jean-Luc Pasquié; Pierre Launay; Sylvain Richard
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

Review 9.  Naturally Engineered Maturation of Cardiomyocytes.

Authors:  Gaetano J Scuderi; Jonathan Butcher
Journal:  Front Cell Dev Biol       Date:  2017-05-05

10.  Mutations in Alström protein impair terminal differentiation of cardiomyocytes.

Authors:  Lincoln T Shenje; Peter Andersen; Marc K Halushka; Cecillia Lui; Laviel Fernandez; Gayle B Collin; Nuria Amat-Alarcon; Wendy Meschino; Ernest Cutz; Kenneth Chang; Raluca Yonescu; Denise A S Batista; Yan Chen; Stephen Chelko; Jane E Crosson; Janet Scheel; Luca Vricella; Brian D Craig; Beth A Marosy; David W Mohr; Kurt N Hetrick; Jane M Romm; Alan F Scott; David Valle; Jürgen K Naggert; Chulan Kwon; Kimberly F Doheny; Daniel P Judge
Journal:  Nat Commun       Date:  2014-03-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.